Stella Pharma (TSE:4888) Marketable Securities : 円200.1 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Stella Pharma's Marketable Securities for the quarter that ended in Sep. 2024 was 円200.1 Mil.

Stella Pharma's annual Marketable Securities stayed the same from Mar. 2022 (円0.0 Mil) to Mar. 2023 (円0.0 Mil) but then increased from Mar. 2023 (円0.0 Mil) to Mar. 2024 (円300.9 Mil).

Stella Pharma Marketable Securities Historical Data

The historical data trend for Stella Pharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Marketable Securities Chart

Stella Pharma Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

300.94

Stella Pharma Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Marketable Securities	Get a 7-Day Free Trial												-	-	301.39	300.94	200.10

Stella Pharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Stella Pharma (TSE:4888) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Stella Pharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043

Website

https://stella-pharma.co.jp

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines